Zevra Therapeutics Inc (ZVRA)
8.40
+0.25
(+3.07%)
USD |
NASDAQ |
Nov 01, 16:00
8.405
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Price to Book Value: 13.61 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 13.61 |
| October 31, 2024 | 13.20 |
| October 30, 2024 | 13.66 |
| October 29, 2024 | 13.38 |
| October 28, 2024 | 13.04 |
| October 25, 2024 | 12.56 |
| October 24, 2024 | 12.80 |
| October 23, 2024 | 12.98 |
| October 22, 2024 | 13.51 |
| October 21, 2024 | 13.84 |
| October 18, 2024 | 13.75 |
| October 17, 2024 | 13.82 |
| October 16, 2024 | 13.71 |
| October 15, 2024 | 13.58 |
| October 14, 2024 | 13.09 |
| October 11, 2024 | 13.22 |
| October 10, 2024 | 12.83 |
| October 09, 2024 | 13.72 |
| October 08, 2024 | 13.56 |
| October 07, 2024 | 12.62 |
| October 04, 2024 | 11.66 |
| October 03, 2024 | 11.63 |
| October 02, 2024 | 11.54 |
| October 01, 2024 | 11.10 |
| September 30, 2024 | 11.24 |
| Date | Value |
|---|---|
| September 27, 2024 | 11.21 |
| September 26, 2024 | 11.84 |
| September 25, 2024 | 12.22 |
| September 24, 2024 | 13.40 |
| September 23, 2024 | 12.28 |
| September 20, 2024 | 13.06 |
| September 19, 2024 | 12.99 |
| September 18, 2024 | 12.69 |
| September 17, 2024 | 12.20 |
| September 16, 2024 | 12.60 |
| September 13, 2024 | 12.72 |
| September 12, 2024 | 12.30 |
| September 11, 2024 | 11.97 |
| September 10, 2024 | 11.70 |
| September 09, 2024 | 11.71 |
| September 06, 2024 | 11.86 |
| September 05, 2024 | 11.71 |
| September 04, 2024 | 11.65 |
| September 03, 2024 | 11.83 |
| August 30, 2024 | 12.39 |
| August 29, 2024 | 11.97 |
| August 28, 2024 | 11.76 |
| August 27, 2024 | 11.68 |
| August 26, 2024 | 11.45 |
| August 23, 2024 | 11.63 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.139
Minimum
May 11 2022
13.84
Maximum
Oct 21 2024
3.420
Average
2.52
Median
Oct 18 2021
Price to Book Value Benchmarks
| Vanda Pharmaceuticals Inc | 0.5007 |
| BioCardia Inc | -- |
| Xeris Biopharma Holdings Inc | -- |
| Crinetics Pharmaceuticals Inc | 5.462 |
| Instil Bio Inc | 0.9598 |
Price to Book Value Related Metrics
| PS Ratio | 14.00 |
| PEG Ratio | -0.0206 |
| Price | 8.40 |
| Earnings Yield | -20.00% |
| Market Cap | 441.99M |
| PEGY Ratio | -0.0206 |